Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
36.15
-0.93 (-2.51%)
Dec 15, 2025, 4:00 PM EST - Market closed
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$6,594,278
Market Cap
4.09B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36 | 9 | 33.33% |
| Dec 31, 2023 | 27 | 6 | 28.57% |
| Dec 31, 2022 | 21 | 3 | 16.67% |
| Dec 31, 2021 | 18 | -2 | -10.00% |
| Dec 31, 2020 | 20 | 1 | 5.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VKTX News
- 3 days ago - My Top 10 Stocks to Buy for 2026 - The Motley Fool
- 4 days ago - 3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026 - The Motley Fool
- 9 days ago - Viking Therapeutics: Prepping For A Critical 2026 - Seeking Alpha
- 18 days ago - Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 - The Motley Fool
- 20 days ago - Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 23 days ago - 2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon - The Motley Fool
- 24 days ago - 3 Weight-Loss Drug Stocks To Consider For 2026 - Benzinga
- 25 days ago - 3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential - The Motley Fool